Biotechnology, Pharmaceutical and Life Science Reports and Courses

Main Pages

Best Selling Products

BioNewsCast Press Release Distribution Service

Vaccine Technology 2009 Conference

Veterinary Diagnostics Markets

Practical Guide to Finding Partners in Pharma & Biotech, 2nd edition

Royalty Financing Agreements in Pharma, Biotech and Diagnostics

New Products

Attention Deficit Hyperactivity Disorder: Diagnosis and Treatment

Bioinformatics Market Potential

Biotechnology in the European Union; Trends, Investing & Country Profiles

China Pharmaceutical Industry: Analysis and Market Trends

European Generic Drug Market Potential

Global Biotechnology Markets Trends

Strategic Alliances in World Pharma and Biotech Markets

Understanding China's Chemical Industry

Understanding Genomics and Global Health Impacts

Understanding Pharmacogenomics

BioPortfolio | Best Practices Reports | Managed Markets Market Research: Effective Structures & Activities for Gaining Maximum Payer Access & Insight

Managed Markets Market Research: Effective Structures & Activities for Gaining Maximum Payer Access & Insight

This benchmark research study examines the corporate structures and activities for Managed Markets market research that are most effective for gaining payer insights and identifies best practices from Managed Markets market research executives. Directors, managers, and executives who oversee market research serving the Managed Markets function will be able to use the benchmark metrics and executive insights in this report to gain maximum payer access and insights.

STUDY OVERVIEW

Commercial success of pharmaceutical products today depends increasingly upon understanding the needs of the commercial and government payers in the highly-influential Managed Markets sector. In response, savvy bio-pharmaceutical companies are seeking to improve their access to payers to develop the best possible Managed Markets insights before product launch. This benchmark research study examines the corporate structures and activities for Managed Markets market research (MMMR) that are most effective for gaining payer insights an identifies best practices from Managed Markets market research executives at 11 leading pharmaceutical and biotechnology companies. Directors, managers and executives who oversee market research serving the Managed Markets function will be able to use the benchmark metrics and executive insights in this report to gain maximum payer access and insights.

KEY TOPICS

Structure and organizational fit of function- Major pre-launch objectives of MMMR- Most effective activities for accessing hard-to-reach channel partners- Primary drivers of MMMR activities- Most critical pre-launch study types- Trends in staffing and focus- Advantages of dedicating resources for the function- Use of performance warranties- Job level of function’s leadership- Key roles and responsibilities- Timing of key activities- Best practices- Pitfalls and Lessons Learned

KEY METRICS-

Functional home of MMMR- Organization to which MMMR reports- Job level of MMMR leader- Effectiveness of current organizational structure- Principal drivers of activities- Percentage of qualitative vs. quantitative research- Top pre-launch objectives for MMMR- Global activities with greatest impact on strategic choices- Most effective activities for gaining insights on the overall MM sector- Most effective activities for gaining insights on hard-to-reach MM channel partners- Most effective activities for gaining access to hard-to-reach MM channel partners- Performance of activities by product development phase- Changes in research focus over the past 18 months- Top 3 most important types of pre-launch studies- Changes in staffing/resource levels for MMMR in past 18 monthsMETHODOLOGYThe research involved participants from 11 leading pharmaceutical and biotechnology companies. Managed Markets executives at 10 companies contributed data and insights in an online survey. Best Practices, LLC analysts also conducted in-depth interviews with six of the research participants to develop executive insights and success factors.

INDUSTRIES PROFILED

Health Care; Pharmaceutical; Biotech; ChemicalCOMPANIES PROFILEDAbbott; Jazz Pharmaceuticals; Amgen; Alcon; GlaxoSmithKline; Johnson & Johnson; Novo Nordisk; Sepracor; Solvay America; Ther-Rx; Xanodyne Pharmaceuticals

Pages: 64

Publication: 17/07/2009

Format: PDF
Table of Contents
Table of Contents PDF
Price: $3,995.00 / €2,670.26

BioPortfolio uses RBS Worldpay Secure Server for credit card transactions